Exelixis
EXEL
#2109
Rank
A$11.30 B
Marketcap
$39.63
Share price
-1.53%
Change (1 day)
18.25%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $73.87 AUD on 2000-07-26

Lowest end of day price: $1.93 AUD on 2014-12-24

Stock price history of Exelixis from 2000 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$61.20-1.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
$86.44-1.08%๐Ÿ‡ซ๐Ÿ‡ท France
$175.74-0.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$74.11 0.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$506.03 0.43%๐Ÿ‡บ๐Ÿ‡ธ USA
$246.22-0.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$44.13-0.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.86-0.34%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.50 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA